HUMINSULIN 50/50

Huminsulin 50/50 Suspension for Injection 40 IU/ml is composed of a blend of intermediate-acting and short-acting insulin, formulated to assist in managing diabetes mellitus for both type 1 and type 2 patients, including children and adults. This medication is essential for achieving better control over glucose levels in diabetic individuals. It is important to note that the usage of Huminsulin 50/50 is typically combined with other diabetes treatment options as part of a comprehensive management plan. Patients will receive guidance from healthcare professionals on the proper technique for subcutaneous injection. After administering the insulin, it is crucial for patients to consume a carbohydrate-containing meal within 30 minutes. Discontinuing the use of this medication should only occur upon the advice of a healthcare provider. In addition to medication, a holistic treatment approach should include a balanced diet, regular physical activity, and weight management as recommended by a doctor. Monitoring blood glucose levels consistently is vital to tailor the appropriate dosage for each individual. The primary adverse effect linked with this medication is hypoglycemia, or low blood sugar, which can be avoided by ensuring correct dosing and meal timing. Additionally, patients may experience injection site reactions, weight gain, rashes, swelling, or itching. It is essential to refrain from using this insulin if experiencing low glucose levels and to inform a doctor of any history of kidney, liver, or heart issues prior to starting treatment. Pregnant or nursing women should also seek medical guidance regarding any necessary dosage adjustments.